ArticleJournal of opioid management

Sublingual buprenorphine/naloxone for chronic pain in at-risk patients: development and pilot test of a clinical protocol.

Andrew Rosenblum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.